Immediate Impact

3 from Science/Nature 79 standout
Sub-graph 1 of 20

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1
2023 StandoutNature
5 intermediate papers

Works of John Raffalli being referenced

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia
2005
A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia
2000

Author Peers

Author Last Decade Papers Cites
John Raffalli 849 559 70 206 15 1.0k
Caroline Maslo 693 485 62 163 38 1.2k
Kathryn Cann 382 715 160 164 14 1.4k
Maria Merelli 666 460 63 77 29 1.2k
F. Meunier–Carpentier 666 563 72 101 29 1.3k
R J van Ketel 272 462 64 174 25 1.2k
John Harkness 438 521 136 191 28 1.0k
A.J.L. Weersink 348 428 62 141 36 1.3k
Jennifer S. Daly 633 421 160 346 35 1.1k
Eddie Louie 458 610 119 56 25 889
Raj B. Uttamchandani 590 758 324 228 11 1.2k

All Works

Loading papers...

Rankless by CCL
2026